Guangdong Kanghua Healthcare Group Co., Ltd.

DB:E9Q Stock Report

Market Cap: €100.5m

Guangdong Kanghua Healthcare Group Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Wangzhi Chen

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentage85.7%
CEO tenure9.1yrs
CEO ownershipn/a
Management average tenure8.6yrs
Board average tenure9.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Wangzhi Chen's remuneration changed compared to Guangdong Kanghua Healthcare Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥51m

Mar 31 2024n/an/a

CN¥86m

Dec 31 2023CN¥1mCN¥1m

CN¥121m

Sep 30 2023n/an/a

CN¥118m

Jun 30 2023n/an/a

CN¥115m

Mar 31 2023n/an/a

CN¥87m

Dec 31 2022CN¥2mCN¥1m

CN¥60m

Sep 30 2022n/an/a

CN¥59m

Jun 30 2022n/an/a

CN¥59m

Mar 31 2022n/an/a

CN¥76m

Dec 31 2021CN¥2mCN¥1m

CN¥94m

Sep 30 2021n/an/a

CN¥103m

Jun 30 2021n/an/a

CN¥112m

Mar 31 2021n/an/a

CN¥43m

Dec 31 2020CN¥2mCN¥2m

-CN¥25m

Sep 30 2020n/an/a

-CN¥63m

Jun 30 2020n/an/a

-CN¥100m

Mar 31 2020n/an/a

-CN¥13m

Dec 31 2019CN¥2mCN¥2m

CN¥74m

Sep 30 2019n/an/a

CN¥112m

Jun 30 2019n/an/a

CN¥150m

Mar 31 2019n/an/a

CN¥159m

Dec 31 2018CN¥2mCN¥2m

CN¥168m

Compensation vs Market: Wangzhi's total compensation ($USD200.83K) is below average for companies of similar size in the German market ($USD462.70K).

Compensation vs Earnings: Wangzhi's compensation has been consistent with company performance over the past year.


CEO

Wangzhi Chen (53 yo)

9.1yrs

Tenure

CN¥1,470,000

Compensation

Mr. Wangzhi Chen is Co-Owner of Dongguan Xingda Property Investment Co., Ltd. Mr. Chen serves as Chief Executive Officer of Guangdong Kanghua Healthcare Co., Ltd. Mr. Chen has been Executive Director at Gu...


Leadership Team

NamePositionTenureCompensationOwnership
Junyang Wang
Executive Chairman of the Board9.1yrsCN¥180.00k66.54%
€ 66.9m
Wangzhi Chen
CEO & Executive Directorno dataCN¥1.47mno data
Wai Hung Wong
Executive Vice Chairman9.1yrsCN¥180.00kno data
Aiqin Wang
Executive Directorno dataCN¥303.00kno data
Wai Hang Wong
CFO, Joint Company Secretary & Secretary to the Board9.1yrsno datano data
Baizhi Wang
Vice General Manager of Operation8.6yrsno datano data
Hing Ling Chau
Joint Company Secretary8.6yrsno datano data
Li Chen
Financial Controller8.6yrsno datano data

8.6yrs

Average Tenure

48.5yo

Average Age

Experienced Management: E9Q's management team is seasoned and experienced (8.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Junyang Wang
Executive Chairman of the Board9.1yrsCN¥180.00k66.54%
€ 66.9m
Wangzhi Chen
CEO & Executive Director9.1yrsCN¥1.47mno data
Wai Hung Wong
Executive Vice Chairman9.1yrsCN¥180.00kno data
Aiqin Wang
Executive Director9.1yrsCN¥303.00kno data
Keji Chen
Independent Non-Executive Director8.6yrsCN¥120.00kno data
Sing Nun Chan
Independent Non-Executive Director9.1yrsCN¥120.00kno data
Yubo Lv
Non-Executive Director8.6yrsno datano data
Ming Lai Yeung
Independent Non-Executive Director8.6yrsCN¥120.00kno data
Shaoming Chen
Chairman of the Supervisory Committee9.1yrsno datano data
Shaofeng Wang
Member of Supervisory Committee9.1yrsno datano data
Chunyang Yue
Member of Supervisory Committee6.3yrsno datano data

9.1yrs

Average Tenure

49yo

Average Age

Experienced Board: E9Q's board of directors are considered experienced (9.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 10:35
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Kanghua Healthcare Group Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ruyi TangBOCI Research Ltd.
Jing QiangChina International Capital Corporation Limited
Yue-Kwong LuiChina Renaissance Securities